Workflow
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
Globenewswire· 2025-11-06 21:00
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address key limitations of targeted RNA-sequencing (RNA-seq) panels in detecting therapeutically-relevant gene rearrangements in acute leukemias. This peer-reviewed publication, entitled “Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene ...
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
Globenewswire· 2025-11-06 21:00
— Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks— —New Clinical Data Provides Insights on Nebokitug’s Direct Macrophage-Mediated Mechanisms that Are Key to PSC Disease Progression— —All Three Presentations Have Been Designated as Posters of Distinction— TEL AVIV, Israel and WASHINGTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical sta ...
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Globenewswire· 2025-11-06 21:00
Company is progressing its previously initiated strategic review evaluating a range of options to maximize shareholder value, including assessment of internal pipeline opportunities and broader strategic alternatives12-week, non-clinical toxicology study of VYN202 in dogs to remedy the partial hold in male clinical subjects is ongoing; Company continues to evaluate potential opportunities for VYN202 as a treatment for serious, immune-mediated diseases Cash runway into first half of 2027 based on previously ...
*MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
Globenewswire· 2025-11-06 21:00
活动核心观点 - 公司作为国际足联世界杯26的官方电信服务赞助商 推出首个“金票”抽奖活动 为客户提供前所未有的场边观赛体验 [1][4] 活动内容与细节 - 活动提供数百张“金票” 获奖客户可在比赛期间进入场地 在场边观看部分赛事 [1] - 抽奖活动由大卫·贝克汉姆参与启动 其他明星阵容包括蒂姆·霍华德 阿丽莎和吉赛尔·汤普森 以及丘基·洛萨诺 [2] - 2026年公司将继续赠送数千张免费比赛门票 包括数百张场边观赛“金票” 以及一系列客户惊喜 特别活动和商品合作等 [3] 活动参与方式 - 抽奖参与时间为11月6日至11月20日 [5] - 客户可通过My Verizon应用程序中的Verizon Access专属入口参与抽奖 [6] - 非客户可前往附近门店或访问官方网站以获取参与机会 [6]
BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat)
Globenewswire· 2025-11-06 21:00
–  Findings highlight negative psychosocial impact of HAE attacks and resulting ED/hospital visits on pediatric patients and their caregivers – –  ORLADEYO oral granules demonstrated early and sustained reduction in HAE attacks over one year of treatment in second interim analysis of APeX-P – –  ORLADEYO oral granules are currently under review with U.S. FDA for ages 2 to <12 with decision expected by end of year; would be first and only targeted oral prophylactic therapy for patients with HAE age 2 to <12 ...
Asure Software Sets November and December 2025 Investor Conference Schedule
Globenewswire· 2025-11-06 21:00
AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management software solutions, is scheduled to participate at the following financial conferences during November and December 2025: 16th Annual Craig-Hallum Alpha Select ConferenceDate: Tuesday November 18, 2025Format: 1x1 MeetingsLocation: New York, NY Roth Technology ConferenceDate: Wednesday November 19, 2025Format:1x1 MeetingsLocation: New York, NY Stephens Annual Invest ...
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Globenewswire· 2025-11-06 21:00
- Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and Q12W dosing had comparable efficacy and safety to omalizumab at Q4W dosing - Completed $250 million public offering to strengthen balance sheet SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopha ...
The Home Depot Foundation invests an additional $30 million to help thousands of veterans access, stay in homes
Prnewswire· 2025-11-06 21:00
Accessibility StatementSkip Navigation While the country has made significant progress toward ensuring our nation's heroes have access to housing – reducing the number of veterans experiencing homelessness by more than 55 percent since 2010 – there's still work to do. On any given night, nearly 33,000 veterans don't have a safe place to sleep or call home. Of those who do, more than 2.75 million live in inadequate housing. At a time when home inventory continues to lag behind demand and the cost of rent cli ...
Disney's ESPN, Penn Entertainment to wind down sports betting partnership, ESPN Bet
CNBC· 2025-11-06 21:00
The ESPN Bet logo on a laptop arranged in New York, US, on Thursday, Feb. 22, 2024.Disney's ESPN and Penn Entertainment are terminating their sports betting partnership, bringing an end to the ESPN Bet brand on Penn's sportsbook years earlier than planned. The partnership, which came together in 2023, allowed for ESPN to rebrand and relaunch Penn's sportsbook — then known as Barstool Sportsbook — as ESPN Bet. The agreement had a 10-year term. On Thursday, Penn and ESPN announced they have mutually agreed to ...
OptimumBank Holdings, Inc., to Announce Third Quarter 2025 Results and Host Earnings Webcast on November 13, 2025
Globenewswire· 2025-11-06 21:00
FT. LAUDERDALE, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (NYSE American: OPHC), announced today that it will release its financial results for the third quarter ended September 30, 2025, before the market opens on Thursday, November 13, 2025. The Company’s management team will host a conference call and live webcast that morning at 10:00 A.M. Eastern Time to review the quarterly results and provide a business update. Current and prospective investors are invited to attend the webca ...